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• Three or more of the following: 
• Elevated Waist Circumference  
o In men: >102 cm  
o In women: >88 cm 
• Hypertriglyceridemia  
o ≥150 mg/dL 
• Low HDL-Cholesterol  
o In men: <40 mg/dL 
o In women: <50 mg/dL 
• High Blood Pressure 
o ≥130/85 mmHg 
• Elevated Fasting Blood Glucose 
o ≥100 mg/dL 
Metabolic Syndrome 
Prevalence  
• Age-adjusted Rates in 1988 – 1994:  
o N = 6,423 
• Overall: 29.2% 
• Men: 31.4% 
• Women: 27.1% 
• Age-adjusted Rates in 1999 – 2006:  
o N = 6,962 
• Overall: 34.2% 
• Men: 34.9% 
• Women:  33.3% 
• Significant increase in prevalence  
(Mozumdar, A., & Liguori, G., 2011)  
 





• History of diabetes 
 
• Environmental factors? 
 
 (Mayo Clinic, 2013)  
 
Chlordane 
• Used in United States from 1948 
– 1988 
o Pesticide on crops, lawns, gardens & 
in buildings 
o Termites & fire ant control  
• Persistent organic pollutant in 
environment 
o Fastens powerfully to the soil  
o Can stay in soil for >20 years due to 
slow breakdown 
o Builds up & stored in animal products 
in our food supply 
o Exposure: food & air in treated homes 
(National Pesticide Information Center, 2001) 
(Agency for Toxic Substances & Disease Registry, 1995)  
Chlordane 
• In the body: 
o Chlordane is transformed into variety 
of metabolites 
o Oxychlordane is the most common 
o Stored in our fat tissue 
• Mechanism of Action: 
o Damage mitochondria in liver & 
muscle 
• Important organelle in 
metabolism 
o Impacts expression of genes that 
create proteins important in 
triglyceride & cholesterol synthesis 
(Lim S, Cho Y, Park K, Lee H., 2010) 
(Ruzzin J, Petersen R, Frøyland L, et al., 2010)  
Research on Chlordane 
• Previous epidemiological research has 
identified an association between 
chlordane & negative health impacts 
o Higher risk of Type 2 Diabetes  
• (Airaksinen R, Rantakokko P, Eriksson J, Blomstedt P, Kajantie E, 
Kiviranta H., 2011) 
o Increased BMI in men 
• (Elobeid, M., Padilla, M., Brock, D., Ruden, D., & Allison, D., 2010) 
o Hypertriglyceridemia  
• (Lee, D., Lee, I., Porta, M., Steffes, M., & Jacobs, D., 2007) 
My Research 
NHANES 
• CDC’s National Health And 
Nutrition Examination Survey 
o Assesses the health & nutritional 
status of adults & children in the 
U.S. 
o About 10,000 people every 2 yrs 
o Nationally representative 
• Includes an interview, physical 
exam & a lab component 
o Examples: blood pressure, diet 
behavior, balance, acculturation, 
mental health assessments, blood 
albumin & much more 
Methods 
• Utilized data from 1999 – 2004 (N=31,126) 
• Sampled non-pregnant, non-lactating & 
fasted adults ≥20 years old 
o N = 3465 
• Utilized statistical analysis           
software SAS 9.2 
• Log transformed oxychlordane data  
• Used logistic regression 
• All results are: 
o Adjusted for age, gender & ethnicity 





Descriptive Characteristics of Adults ≥20 years old, NHANES, 1999-2004 (n=3465) 
Demographics Mean ± SE 
Oxychlordane, lipid-adjusted 18.03 ±17.43 
Age (years) 46.57 ± 16.80 
Gender Frequency, % 
Women 50.67 
Ethnicity Frequency, % 
NH White 72.84 
NH Black 9.98 
Mexican American 7.41 
Other Race/Ethnicity 9.77 
Metabolic Syndrome Risk Factors Mean ± SE 
Diastolic Blood Pressure 71.94 ± 13.10 
Systolic Blood Pressure 123.84 ± 19.24 
HDL Cholesterol 52.03 ± 15.43 
Fasting Glucose 101.86 ± 29.83 
Triglyceride 153.12 ± 125.37 





• Elevated blood levels of oxychlordane is associated with: 
o Metabolic syndrome 
o Hypertriglyceridemia 
o Hyperglycemia 
o Elevated waist circumference 
o High blood pressure 
• Although chlordane has not been commercially available 
since 1988, it persists in our environment & in the food 
Americans consume 
• In addition to lifestyle factors, risk of chronic disease is 
influenced by environmental factors 
• This is only one of many pesticides that the U.S. has & is 
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